Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.

[1]  A. von Deimling,et al.  Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. , 2011, International journal of radiation oncology, biology, physics.

[2]  Steven D Chang,et al.  Cyberknife Stereotactic Radiosurgery for Treatment of Atypical (Who Grade II) Cranial Meningiomas , 2010, Neurosurgery.

[3]  A. von Deimling,et al.  Carbon ion radiation therapy for high-risk meningiomas. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Pascal Pommier,et al.  Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. , 2009, International journal of radiation oncology, biology, physics.

[5]  G. Barnett,et al.  Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. , 2009, International journal of radiation oncology, biology, physics.

[6]  W. Curry,et al.  LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION , 2009, Neurosurgery.

[7]  J. Reijneveld,et al.  Source (or Part of the following Source): Type Article Title Late Neurocognitive Sequelae in Patients with Who Grade I Meningioma Author(s) , 2022 .

[8]  B. Guthrie,et al.  Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. , 2008, Neurosurgical focus.

[9]  R. Mirimanoff,et al.  Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. , 2007, International journal of radiation oncology, biology, physics.

[10]  Y. Chung,et al.  Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[11]  W. Schlegel,et al.  Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. , 2007, International journal of radiation oncology, biology, physics.

[12]  J. Reijneveld,et al.  Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients , 2007, Journal of Neuro-Oncology.

[13]  D. Macarthur,et al.  Atypical meningiomas: WHO moved the goalposts? , 2007, British journal of neurosurgery.

[14]  U. Sure,et al.  Clinicopathologic Features of Aggressive Meningioma Emphasizing the Role of Radiotherapy in Treatment , 2006, Strahlentherapie und Onkologie.

[15]  W. Schlegel,et al.  Fractionated Stereotactic Radiation Therapy in the Management of Benign Cavernous Sinus Meningiomas , 2006, Strahlentherapie und Onkologie.

[16]  U. Haberkorn,et al.  Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. , 2006, International journal of radiation oncology, biology, physics.

[17]  J. Schramm,et al.  Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  I. Whittle,et al.  The accuracy of meningioma grading: a 10‐year retrospective audit , 2005, Neuropathology and applied neurobiology.

[19]  W. Schlegel,et al.  Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. , 2005, International journal of radiation oncology, biology, physics.

[20]  W. Mendenhall,et al.  Pushing the Limits of Radiotherapy for Atypical and Malignant Meningioma , 2005, American journal of clinical oncology.

[21]  M. McDermott,et al.  Surgical Resection and Permanent Brachytherapy for Recurrent Atypical and Malignant Meningioma , 2004, Neurosurgery.

[22]  R. Ojemann,et al.  Management of Atypical and Malignant Meningiomas: Role of High-dose, 3D-conformal Radiation Therapy , 2000, Journal of Neuro-Oncology.

[23]  M. Bondy,et al.  Epidemiology and etiology of intracranial meningiomas: A review , 1996, Journal of Neuro-Oncology.

[24]  B. Rhein,et al.  Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. , 2003, International journal of radiation oncology, biology, physics.

[25]  W. Yung,et al.  PATHOLOGY AND GENETICS OF TUMOURS OF THE NERVOUS SYSTEM , 2002 .

[26]  J. Debus,et al.  High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Berger,et al.  Radiosurgery for malignant meningioma: results in 22 patients. , 2000, Journal of neurosurgery.

[28]  W. Simpson,et al.  Radiotherapy for atypical or malignant intracranial meningioma. , 1996, International journal of radiation oncology, biology, physics.

[29]  B. Scheithauer,et al.  Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.

[30]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.